Blood Research

Cited by CrossRef (4)

  1. Mohamed Eid, Ali M Kasem, Yasser M Kamal, Mahmoud Hamdy, Mahmoud Gaber. Prevalence and predictors of pulmonary hypertension in patients with myeloproliferative neoplasms: single-center study. EGJH 2024;49:45
    https://doi.org/10.4103/ejh.ejh_92_23
  2. Keiji Minakawa, Tetsuro Yokokawa, Koki Ueda, Osamu Nakajima, Tomofumi Misaka, Yusuke Kimishima, Kento Wada, Yusuke Tomita, Saori Miura, Yuka Sato, Kosaku Mimura, Koichi Sugimoto, Kazuhiko Nakazato, Kenneth E. Nollet, Kazuei Ogawa, Takayuki Ikezoe, Yuko Hashimoto, Yasuchika Takeishi, Kazuhiko Ikeda. Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice. J Hematol Oncol 2021;14
    https://doi.org/10.1186/s13045-021-01064-8
  3. Ik-Chan Song, Sang-Hoon Yeon, Myeong-Won Lee, Hyewon Ryu, Hyo-Jin Lee, Hwan-Jung Yun, Byung Joo Sun, Jae-Hyeong Park, Jin-Ok Jeong, Deog-Yeon Jo. Pulmonary hypertension in patients with chronic myeloid leukemia. 2021;100:e26975
    https://doi.org/10.1097/MD.0000000000026975
  4. David Montani, Pierre Thoré, Xavier Mignard, Xavier Jaïs, Athénaïs Boucly, Mitja Jevnikar, Andrei Seferian, Etienne-Marie Jutant, Vincent Cottin, Elie Fadel, Gérald Simonneau, Laurent Savale, Olivier Sitbon, Marc Humbert. Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study. Am J Respir Crit Care Med 2023;208:600
    https://doi.org/10.1164/rccm.202210-1941OC
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd